Dark Forest Capital Management LP Verve Therapeutics, Inc. Transaction History
Dark Forest Capital Management LP
- $2.34 Billion
- Q2 2025
A detailed history of Dark Forest Capital Management LP transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Dark Forest Capital Management LP holds 12,648 shares of VERV stock, worth $140,772. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,648
Previous 81,125
84.41%
Holding current value
$140,772
Previous $370,000
61.62%
% of portfolio
0.01%
Previous 0.02%
Shares
10 transactions
Others Institutions Holding VERV
# of Institutions
190Shares Held
72.1MCall Options Held
452KPut Options Held
2.96M-
Alphabet Inc. Mountain View, CA12.2MShares$135 Million8.86% of portfolio
-
Pentwater Capital Management LP Naples, FL6.72MShares$74.8 Million0.5% of portfolio
-
Black Rock Inc. New York, NY6.62MShares$73.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.19MShares$46.7 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY4.1MShares$45.6 Million6.45% of portfolio
About Verve Therapeutics, Inc.
- Ticker VERV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,942,300
- Market Cap $667M
- Description
- Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...